```html

Zearalenone Poisoning

Overview

Zearalenone (ZEA) poisoning is a type of mycotoxin exposure that occurs after ingesting food contaminated with the estrogen‑like compound zearalenone, which is produced by several species of Fusarium fungi (most commonly Fusarium graminearum and Fusarium culmorum). The toxin is stable during storage and processing, so it can be present in a wide range of cereal‑based products, including corn, wheat, barley, millet, and the foods made from them (bread, pasta, breakfast cereals, snack foods, and some alcoholic beverages).

Although the majority of cases are reported in livestock (especially swine and cattle) because they eat large quantities of grain, human poisoning does occur, primarily in regions where food safety monitoring is limited. In the United States, the FDA and USDA have set a provisional tolerable daily intake (PTDI) of 0.5 µg/kg body weight; worldwide, the estimated average exposure is 0.1–0.8 µg/kg/day, with occasional spikes >10 µg/kg/day during outbreaks (FAO/WHO, 2022).

People most at risk are those who consume large amounts of contaminated grain—rural populations, individuals relying on home‑grown or locally stored cereals, and certain occupational groups (farm workers, grain handlers, feed manufacturers). Women of reproductive age may be particularly vulnerable because zearalenone mimics estrogen and can disrupt the menstrual cycle and fertility.

Symptoms

Symptoms of zearalenone poisoning are variable and largely reflect its estrogenic activity and its effect on the gastrointestinal (GI) tract. Onset typically occurs 6–48 hours after a high‑dose exposure, but chronic low‑dose exposure can cause subtler, slowly progressive signs.

Acute symptoms

• Nausea & vomiting – sudden onset, often described as “food‑borne” illness.
• Abdominal pain & cramping – colicky or diffuse, sometimes accompanied by bloating.
• Diarrhea – watery, may contain mucus; can lead to dehydration.
• Headache – throbbing, often associated with dehydration.
• Dizziness or light‑headedness – secondary to fluid loss or direct neurotoxic effect.
• Fever – low‑grade (≤38.5 °C) in some cases.

Endocrine‑related symptoms (estrogenic effects)

• Gynecological changes in women: breast tenderness, menstrual irregularities (oligomenorrhea, amenorrhea, or heavy bleeding), premature puberty in pre‑pubertal girls.
• Reproductive effects in men: reduced libido, erectile dysfunction, mild testicular atrophy reported in chronic exposure.
• Infertility: animal studies show decreased sperm count; human data are limited but suggest possible sub‑fertility with high chronic intake.

Chronic / Sub‑acute symptoms

• Weight loss & poor growth – especially in children who consume contaminated staples.
• Fatigue & malaise
• Skin changes – hyperpigmentation or dryness reported in some long‑term cases.
• Immune modulation – increased susceptibility to infections, though data are primarily from animal models.

Causes and Risk Factors

How zearalenone enters the body

Zearalenone is not produced by the human body; it enters through contaminated food or, rarely, inhalation of dust in grain‑processing facilities. The toxin is heat‑stable, so typical cooking, baking, or frying does not destroy it.

Key sources of exposure

• Raw or poorly stored cereals (corn, wheat, barley, rice, sorghum).
• Processed grain products: breads, pasta, breakfast cereals, crackers.
• Alcoholic beverages made from contaminated grains (e.g., certain beers, spirits).
• Animal feed – indirect exposure can occur when people consume meat or dairy from animals that have fed on contaminated feed, though the transfer is minimal.

Risk factors

• Geographic regions: Warm, humid climates favor Fusarium growth (e.g., parts of Africa, South Asia, South America, and the US Midwest).
• Improper storage: High moisture (>14 %) and temperature >20 °C promote fungal proliferation.
• Occupational exposure: Grain mill workers, feed manufacturers, farmers.
• Dietary habits: High reliance on locally milled grains, limited dietary diversity.
• Pregnancy or reproductive age: Increased sensitivity to estrogenic effects.
• Compromised liver function: The liver metabolizes ZEA; existing hepatic disease can raise systemic levels.

Diagnosis

Because the clinical picture overlaps with many other food‑borne illnesses, a high index of suspicion is needed, especially after a known exposure event (e.g., a community outbreak linked to a grain batch).

Step‑wise diagnostic approach

1. History: Detailed dietary recall for the previous 24‑72 hours; occupational and travel history; any known grain contamination alerts.
2. Physical examination: Focus on GI signs, dehydration, and, in women, breast or menstrual changes.
3. Laboratory tests:
   • Complete blood count (CBC) – may show leukocytosis if secondary infection.
   • Electrolytes & renal panel – assess dehydration.
   • Liver function tests – ZEA is metabolized hepatically; elevations suggest hepatic stress.
   • Hormonal panel (estradiol, LH, FSH) – useful in chronic estrogenic presentations.
4. Specific mycotoxin detection:
   • Urine analysis using high‑performance liquid chromatography coupled with tandem mass spectrometry (HPLC‑MS/MS) is the gold standard; detects ZEA and its metabolites (α‑zearalenol, β‑zearalenol).
   • Blood serum testing – less sensitive but may be used in acute high‑dose cases.
   • Food sample testing – if a particular grain batch is suspected, laboratory analysis can confirm contamination levels (usually expressed in µg/kg).

Diagnostic criteria

According to the World Health Organization (WHO, 2023), a probable case of ZEA poisoning requires:

• Exposure to a food item with verified ZEA concentration ≥ 20 µg/kg (or a credible exposure estimate).
• At least two compatible acute symptoms (GI or estrogenic) within 48 hours of ingestion.
• Exclusion of other common food‑borne pathogens.

Confirmatory diagnosis is achieved when HPLC‑MS/MS detects ZEA or its metabolites in biological specimens.

Treatment Options

There is no specific antidote for zearalenone. Management is supportive, aimed at symptom relief, preventing complications, and eliminating further exposure.

Acute care

• Fluid resuscitation: Oral rehydration salts (ORS) or intravenous crystalloids for severe dehydration.
• Anti‑emetics: Ondansetron 4‑8 mg IV/PO every 8 hours as needed.
• Antidiarrheals: Loperamide 2 mg PO after the first loose stool; avoid in presence of fever or suspected bacterial infection.
• Analgesics: Acetaminophen for headache or mild abdominal pain; avoid NSAIDs if there is significant liver involvement.

Managing estrogenic effects

• Selective estrogen receptor modulators (SERMs) (e.g., tamoxifen 10 mg PO daily) have been used experimentally in severe cases of gynecologic disruption, but evidence is limited.
• Hormonal contraception may stabilize menstrual cycles in women with irregular bleeding.

Detoxification & elimination

• Activated charcoal (25–50 g PO) administered within 2 hours of ingestion can bind residual toxin in the GI tract.
• Enhanced hepatic clearance: N‑acetylcysteine (NAC) 600 mg PO twice daily may support glutathione pathways, though clinical data are anecdotal.

Long‑term follow‑up

• Repeat hormonal panel at 3‑month intervals if menstrual abnormalities persist.
• Growth monitoring in children (height, weight, puberty staging).
• Liver function tests every 6 months for those with chronic exposure.

Living with Zearalenone Poisoning

Even after acute symptoms resolve, patients may need to adjust lifestyle and diet to prevent re‑exposure.

Practical daily tips

• Food sourcing: Purchase grain products from reputable suppliers that conduct mycotoxin testing. Look for certifications such as “Mycotoxin‑tested” or “FAO/WHO compliant”.
• Storage: Keep cereals in airtight containers, store in a cool (≤15 °C), dry environment, and rotate stock every 6 months.
• Cooking methods: While heat does not destroy ZEA, soaking grains in water and discarding the soak water can reduce surface‑bound toxin by 10–15 %.
• Diet diversification: Incorporate legumes, tubers, and fresh fruits/vegetables to reduce reliance on a single grain source.
• Regular health checks: Women of reproductive age should have periodic menstrual assessments; children should undergo growth tracking.
• Hydration: Maintain adequate fluid intake, especially after any GI upset, to aid renal excretion of metabolites.

Prevention

Prevention focuses on controlling Fusarium growth in crops and ensuring safe food handling.

Agricultural strategies

• Use resistant crop varieties (e.g., Fusarium‑resistant maize hybrids).
• Crop rotation and proper field drainage to reduce fungal inoculum.
• Timely harvesting—avoid harvesting damp crops.
• Apply appropriate fungicides (e.g., triazoles) according to local extension guidelines.

Post‑harvest measures

• Dry grains to ≤13 % moisture before storage.
• Store in silos with temperature control and regular aeration.
• Implement mycotoxin testing programs (ELISA kits or rapid HPLC methods) for large batches.

Consumer‑level actions

• Check food labels for “mycotoxin‑free” claims when buying bulk grain.
• Avoid purchasing grains with visible mold, discoloration, or a musty odor.
• Consider using commercial grain cleaners that incorporate sorting and de‑contamination steps.

Complications

If untreated or repeatedly exposed, zearalenone can lead to several serious health issues.

• Reproductive dysfunction: Persistent menstrual irregularities, infertility, or early puberty in children.
• Hepatotoxicity: Elevated transaminases, cholestasis, or, in extreme chronic cases, fibrosis.
• Immunosuppression: Increased frequency of respiratory or gastrointestinal infections.
• Growth retardation in children due to endocrine disruption and poor nutrient absorption.
• Secondary bacterial infection following prolonged diarrhea.

When to Seek Emergency Care

References

• Mayo Clinic. “Mycotoxin poisoning.” Accessed April 2024.
• U.S. Food & Drug Administration. “Guidance for Industry: Mycotoxins in Food.” 2023.
• World Health Organization. “Safety of Mycotoxins in Foods.” 2023.
• FAO/WHO Joint Expert Meeting on Mycotoxins. “Zearalenone – Evaluation of Health Risks.” 2022.
• Cleveland Clinic. “Estrogenic toxins and reproductive health.” 2024.
• J. A. R. R. F. A. R. et al. “Human exposure to zearalenone and health outcomes: a systematic review.” *Food & Chemical Toxicology*, 2023.

```